Head and Neck Cancer Patients at Risk of Cognitive Problems Following Treatment (01-8-2018)

CancerConnect News: Patients who survive head and neck cancer may be more likely to experience declines in mental function according to the results of a recent study. The findings are drawn from cognitive assessments for 80 survivors of head and neck... Continue Reading

Cervical Cancer Survivors Frequently Suffer From Long-Term Side Effects of Treatment (08-17-2017)

According to a new study around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes.1 Cervical cancer affects more than 500,000 women around the world each year with an average... Continue Reading

Balance and Gait is Negatively Impacted By Chemotherapy Treatment (07-26-2017)

A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients conducted by researchers at The Ohio State... Continue Reading

Shorter Duration Chemotherapy Possible for Early Stage Colon Cancer (06-26-2017)

Many colon cancer patients can cut their chemotherapy regimen in half, improving their quality of life and reducing their chances of having debilitating side effects, according to the results of a major study released at the American Society of Clinical... Continue Reading

CCNU (12-13-2016)

Class: Chemotherapy Generic Name: lomustine (loh-MUS-teen), CCNU Trade Name: CeeNU® How is this drug used? CeeNU is approved for the treatment of brain tumors, either those that have originated in the brain or have spread to the brain from a different... Continue Reading

Gliadel® wafer (09-22-2016)

Class: Chemotherapy Generic Name: carmustine (kar-MUS-teen), BCNU, Gliadel® wafer Trade Name: BiCNU®  For which conditions is this drug approved? Carmustine is FDA approved for the treatment of the following conditions: several types of brain tumors... Continue Reading

fluorouracil (08-11-2016)

Class: Chemotherapy   Generic Name: fluorouracil (fler-oh-YOO-rah-sil), 5-FU, 5-fluorouracil Trade Name: Adrucil®, Carac®, Efudex® and Fluoroplex® For which conditions is this drug approved? Fluorouracil is FDA approved for the treatment of the following... Continue Reading

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting (07-12-2016)

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting. Syndros is an oral formulation comparable to the... Continue Reading

Chemotherapy After Prostatectomy Delays Cancer Progression in High-Risk Prostate Cancers (05-17-2016)

The use of chemotherapy following a radical prostatectomy delays the time to cancer progression among men with prostate cancer who are at a high risk of developing a recurrence.  These results were recently presented at the 2016 Annual Scientific Meeting... Continue Reading

Halaven® (05-10-2016)

Class: Chemotherapy Generic Name: Eribulin Trade Name: Halaven® For which conditions is this drug approved? Halaven is approved for metastatic breast cancer patients who have had at least two chemotherapy regimens for metastatic disease, including... Continue Reading

Next Page »